ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,632.33
1.05%
Dow Jones
41,488.19
1.65%
Gold vs US Dollar
2,986.65
0.00%
Brent Oil
70.285
0.00%
Bitcoin
84,222.10
0.31%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. GeneDx Holdings Corporation (WGS)

  7. GeneDx Holdings Corporation (WGS) News

GeneDx (WGS)

GeneDx Holdings Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:WGS
DateTimeSourceHeadlineSymbolCompany
24/02/202516:00Business WireLandmark Seqfirst-neo Study Showcases the Significant Impact of Genomic Testing in the NICU, Revealing Gaps in Current ProtocolsNASDAQ:WGSGeneDx Holdings Corporation
18/02/202511:00Business WireGeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025NASDAQ:WGSGeneDx Holdings Corporation
13/02/202513:30Business WireGeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU PatientsNASDAQ:WGSGeneDx Holdings Corporation
12/02/202521:05Business WireGeneDx to Participate in 45th Annual TD Cowen Health Care ConferenceNASDAQ:WGSGeneDx Holdings Corporation
10/02/202513:30Business WireGeneDx Integrates with Epic, Enabling Broad Adoption of Genome and Exome Sequencing for Health Systems to Inform Patient Diagnosis and Accelerate TreatmentNASDAQ:WGSGeneDx Holdings Corporation
28/01/202521:30Business WireGeneDx to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 18, 2025NASDAQ:WGSGeneDx Holdings Corporation
17/01/202521:30Business WireGeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:WGSGeneDx Holdings Corporation
13/01/202513:30Business WireGeneDx Announces Preliminary 2024 Financial ResultsNASDAQ:WGSGeneDx Holdings Corporation
09/01/202513:30Business WireGeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking AnswersNASDAQ:WGSGeneDx Holdings Corporation
08/01/202513:30Business WireGeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 PatientsNASDAQ:WGSGeneDx Holdings Corporation
02/01/202521:01Business WireGeneDx Strengthens Executive Leadership Team with Bryan Dechairo Named Chief Operating OfficerNASDAQ:WGSGeneDx Holdings Corporation
16/12/202421:05Business WireGeneDx to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:WGSGeneDx Holdings Corporation
05/12/202413:30Business WireGeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New PartnersNASDAQ:WGSGeneDx Holdings Corporation
22/11/202421:05Business WireGeneDx to Participate in Upcoming Investor ConferenceNASDAQ:WGSGeneDx Holdings Corporation
19/11/202413:30Business WireGeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx DiscoverNASDAQ:WGSGeneDx Holdings Corporation
18/11/202413:30Business WireGeneDx Announces Heidi Chen as Chief Legal Officer and Corporate SecretaryNASDAQ:WGSGeneDx Holdings Corporation
07/11/202421:35Business WireNew GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic YieldsNASDAQ:WGSGeneDx Holdings Corporation
04/11/202421:35Business WireGeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual MeetingNASDAQ:WGSGeneDx Holdings Corporation
29/10/202412:00Business WireGeneDx Reports Third Quarter 2024 Financial Results and Business HighlightsNASDAQ:WGSGeneDx Holdings Corporation
24/10/202415:10Business WireGroundbreaking GUARDIAN Study Shows Benefits of Adding Genome Sequencing to Newborn Screening; Augments and Improves Standard Newborn ScreeningNASDAQ:WGSGeneDx Holdings Corporation
08/10/202412:30Business WireGeneDx to Showcase Data from Largest Genomic Newborn Screening Cohort of 14,000 NewbornsNASDAQ:WGSGeneDx Holdings Corporation
03/10/202420:05Business WireGeneDx to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024NASDAQ:WGSGeneDx Holdings Corporation
27/09/202420:05Business WireGeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:WGSGeneDx Holdings Corporation
04/09/202401:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:WGSGeneDx Holdings Corporation
12/08/202420:05Business WireGeneDx to Participate in Fall Investor ConferencesNASDAQ:WGSGeneDx Holdings Corporation
09/08/202420:05Business WireGeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:WGSGeneDx Holdings Corporation
31/07/202420:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
30/07/202420:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:WGSGeneDx Holdings Corporation
30/07/202420:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WGSGeneDx Holdings Corporation
30/07/202420:05Business WireGeneDx Reports Second Quarter 2024 Financial Results and Business HighlightsNASDAQ:WGSGeneDx Holdings Corporation
 Showing the most relevant articles for your search:NASDAQ:WGS

Your Recent History

BIT
USRIH
Amundi MSCI USA SRI Net0...
AQSE
VLX.GB
Volex
BIT
CBEU5
Ubs Lux Fund Sol Bbg Eur...
TG
AXI
Atos
BIT
WELES
Eles
TSXV
GI.H
Gem International Resour...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads